Join us to discuss what health system leaders and companies have learned during the rapid roll-out of new technologies during COVID-19. What’s worked well? What’s here to stay? And where is there opportunity for improvement?
As Emily mentioned in a previous questions, the COVID pandemic has shifted us to more remote care models putting new technologies in the hands of patients such as home monitoring devices. Do you think we’ll continue to see this shift towards patient-initiated care via new technologies?
The mental health of clinical care providers and teams has been spoken about more loudly and urgently than ever, yet few actionable steps seem to be taken to fundamentally address this. Who are paying for an implementing meaningful solutions in this space?
What COVID innovations are keeping patients at home by providing services traditionally available in the hospital and which of these are here to stay? What policy change would improve patient care at home?
We have seen many physicians not only treat patients with Coronavirus, but also share their expertise through social media platforms (i.e. Twitter) and television (i.e. CNN) as key opinion leaders. The #ThisisOurLane movement has sparked a transition of physicians from traditional roles into those within business, policy, and advocacy. What are the challenges in holding multiple roles / interests, and how should medical school education reflect these additions to "traditional" role of physicians moving forward?
How has the pandemic shifted health systems’ approach to implementing new tech solutions and innovations? Are health systems and practices more open to working with digital health companies? Did their requirements change in response to the PHE?
Monitoring patients outside of the four walls can provide valuable insights, but how does the information get activated? A care team needs to receive, interpret, and respond to that information, bringing both additional time and liability. How are entrepreneurs navigating this? Is anyone doing it particularly well?
From many conversations, I have learned that several healthcare entrepreneurs have resorted to virtual pitches as a means to raise funds for their companies. Pros and cons? What about for women - who have traditionally balanced roles at work and in the household? Will the increased accessibility to investors help address the gap in funding? Are these trends here to stay?
Aside from the really well known things, such as the COVID vaccines and ventilators, I'm curious what products/technologies were granted EUA and how many of those will get converted to full market approval. We heard a lot about the rush to develop ventilators at the start of the pandemic and I know of other wearable data collection products that were applying for EUA. I'm curious what other technologies that were deemed important/useful enough to be granted EUA by the FDA and if the panel sees any of them as having longevity post-COVID.
Hi everyone, thanks so much for joining our panel! This question is for the Innovations that were developed (technology or otherwise) that were created to specifically care for the patients sick with COVID-19. We'll get into other cases of innovation over the past year soon. Looking forward to hearing your thoughts!